
Ibere
IBERIbere Pharmaceuticals Price (IBER)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
No Data
Revenue and Profitability
Year | 2020 | 2021 |
---|---|---|
Revenue | - | 0 |
Net Income | - | 1,561,747 |
FCF USD | - | -868,746 |
OCF USD | - | -868,746 |
Financial Health - DEBT
Year | 2020 | 2021 |
---|---|---|
YTPD | - | 0.00 |
D/E | 8.78 | 0.00 |
CA/CL | 0.27 | 1.86 |
TA/TL | 1.03 | 12.02 |
Total Debt | 169,000 | 0 |
Management Performance
Year | 2020 | 2021 |
---|---|---|
ROIC | - | -0.80% |
ROE | - | 1.23% |
ROA | - | 1.13% |
NM % | - | - |
FCF / R% | - | 0.00% |
FCF / NI% | - | -55.63% |
Operating Margin (OM) | - | - |
Per Share
Year | 2020 | 2021 |
---|---|---|
EPS | 0.00 | 0.11 |
SPS | 0.00 | 0.00 |
OCPS | 0.00 | -0.06 |
FCPS | 0.00 | -0.06 |
BVPS | 0.00 | 8.55 |
Per Share - CAGR
Year | 2020 | 2021 |
---|---|---|
CAGR-EPS | 0.00 | 0.11 |
CAGR-SPS | 0.00 | 0.00 |
CAGR-OCPS | 0.00 | -0.06 |
CAGR-FCPS | 0.00 | -0.06 |
CAGR-BVPS | 0.00 | 8.55 |